Company Overview

Company name: MYM Nutraceuticals (CNQ: MYM)
Description: Provider of bio-pharmaceutical research services intended to produce quality cannabis growing facilities. The company’s bio-pharmaceutical research services include developing high-end organic medicinal marijuana supplements, topical products and distribution license under the marihuana for medical purposes regulations, enabling marijuana producers to expand their brand into the global market.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.mym.ca
Employees: 21
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 16.37
Business status: Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: MYM
Revenue (USD Million): 1.17
Gross profit (USD Million): 0.76
Net income (USD Million) -5.83
Enterprise value: 104.70
Earnings before interest, tax, depreciation and amortization (EBITDA): -5.92
Fiscal period: TTM 1Q2019
Financing Status: The company (CNQ:MYM) received CAD 5.30 million of development capital from undisclosed investors on September 14, 2018 through a private placement.
Number of active investors:
Profile last updated: 19-Sep-2018
Last known valuation:
Last known valuation date: